Cargando…
5-En-androstene-3 beta,17 beta-diol inhibits the growth of MCF-7 breast cancer cells when oestrogen receptors are blocked by oestradiol.
Adrenal androgens show a dual and apparently opposite effect on the growth of oestrogen-responsive breast cancer: they stimulate growth on their own, but counteract the growth-stimulatory effect of oestrogens. Focusing on the inhibitory action we have studied the effects of 5-en-androstene-3 beta,17...
Autores principales: | Boccuzzi, G., Brignardello, E., Di Monaco, M., Gatto, V., Leonardi, L., Pizzini, A., Gallo, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033679/ https://www.ncbi.nlm.nih.gov/pubmed/7981051 |
Ejemplares similares
-
Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol.
por: Clarke, R., et al.
Publicado: (1985) -
Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.
por: Di Monaco, M., et al.
Publicado: (1997) -
Oestradiol-17 beta and prolactin levels in rat peripheral plasma.
por: Hawkins, R. A., et al.
Publicado: (1975) -
A Role for the Androgen Metabolite, 5alpha Androstane 3beta, 17beta Diol (3β-Diol) in the Regulation of the Hypothalamo-Pituitary–Adrenal Axis
por: Handa, Robert J., et al.
Publicado: (2011) -
Serum oestradiol-17 beta, testosterone, luteinizing hormone and follicle-stimulating hormone in males with breast cancer.
por: Ribeiro, G. G., et al.
Publicado: (1980)